Daniel Mønsted Shabanzadeh1, Lars Tue Sørensen2, Torben Jørgensen3. 1. Digestive Disease Center, Bispebjerg University Hospital, Copenhagen, Denmark; Research Centre for Prevention and Health, Capital Region of Denmark, Glostrup, Denmark. Electronic address: daniel.moensted.shabanzadeh.01@regionh.dk. 2. Digestive Disease Center, Bispebjerg University Hospital, Copenhagen, Denmark; Institute for Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. 3. Research Centre for Prevention and Health, Capital Region of Denmark, Glostrup, Denmark; Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark; The Faculty of Medicine, Aalborg University, Denmark.
Abstract
BACKGROUND & AIMS: Knowledge of temporal associations between screen-detected gallstone disease and specific cancers is limited. The objective of this study was to determine if screen-detected gallstones or cholecystectomy are associated with occurrence of gastrointestinal and nongastrointestinal cancers. METHODS: We performed a cohort study of 3 randomly selected groups from the general population of Copenhagen. Participants (N = 5928) were examined from 1982 through 1992 and underwent abdominal ultrasound examination to detect gallstone disease, but were not informed of their gallstone status. Participants were followed for the occurrence of cancers through national registers until December 2014. We performed multivariable Cox regression analyses to identify factors associated with development of cancer. RESULTS: Gallstone disease was identified in 10% of participants (591 of 5928); of these, 6.8% had gallstones and 3.2% had cholecystectomy at baseline. The population was followed for a median of 24.7 years (interquartile range, 18.9-32.4 years) with 1% lost. Pooled gastrointestinal cancers were associated with gallstone disease (11.2% of patients with gallstone disease vs 6.64% without; hazard ratio, 1.50; 95% confidence interval, 1.12-2.01). Right-side colon cancer was also associated with gallstone disease (2.57% of patients with gallstone disease vs 0.96% without; hazard ratio, 2.04; 95% confidence interval, 1.10-3.78). Pancreatic, esophageal, gastric, pooled colorectal, left-side colon, sigmoid colon, and rectal cancers were not associated with gallstone disease. Breast cancer had a weak association with gallstone disease depending on other factors (10.6% of patients with gallstone disease vs 7.41% without; hazard ratio, 1.44; 95% confidence interval, 0.99-2.11). Pooled nongastrointestinal and prostate cancers were not associated with gallstone disease. CONCLUSIONS: Screen-detected gallstone disease in the general population is associated with pooled gastrointestinal and right-side colon cancers. These associations are not due to detection bias or cholecystectomy. Further studies are needed to determine the mechanism of this association.
BACKGROUND & AIMS: Knowledge of temporal associations between screen-detected gallstone disease and specific cancers is limited. The objective of this study was to determine if screen-detected gallstones or cholecystectomy are associated with occurrence of gastrointestinal and nongastrointestinal cancers. METHODS: We performed a cohort study of 3 randomly selected groups from the general population of Copenhagen. Participants (N = 5928) were examined from 1982 through 1992 and underwent abdominal ultrasound examination to detect gallstone disease, but were not informed of their gallstone status. Participants were followed for the occurrence of cancers through national registers until December 2014. We performed multivariable Cox regression analyses to identify factors associated with development of cancer. RESULTS:Gallstone disease was identified in 10% of participants (591 of 5928); of these, 6.8% had gallstones and 3.2% had cholecystectomy at baseline. The population was followed for a median of 24.7 years (interquartile range, 18.9-32.4 years) with 1% lost. Pooled gastrointestinal cancers were associated with gallstone disease (11.2% of patients with gallstone disease vs 6.64% without; hazard ratio, 1.50; 95% confidence interval, 1.12-2.01). Right-side colon cancer was also associated with gallstone disease (2.57% of patients with gallstone disease vs 0.96% without; hazard ratio, 2.04; 95% confidence interval, 1.10-3.78). Pancreatic, esophageal, gastric, pooled colorectal, left-side colon, sigmoid colon, and rectal cancers were not associated with gallstone disease. Breast cancer had a weak association with gallstone disease depending on other factors (10.6% of patients with gallstone disease vs 7.41% without; hazard ratio, 1.44; 95% confidence interval, 0.99-2.11). Pooled nongastrointestinal and prostate cancers were not associated with gallstone disease. CONCLUSIONS: Screen-detected gallstone disease in the general population is associated with pooled gastrointestinal and right-side colon cancers. These associations are not due to detection bias or cholecystectomy. Further studies are needed to determine the mechanism of this association.
Authors: Janine Wirth; Mingyang Song; Teresa T Fung; Amit D Joshi; Fred K Tabung; Andrew T Chan; Cornelia Weikert; Michael Leitzmann; Walter C Willett; Edward Giovannucci; Kana Wu Journal: Int J Epidemiol Date: 2018-12-01 Impact factor: 7.196
Authors: Georgios Polychronidis; Kai Wang; Chun-Han Lo; Liang Wang; Mingming He; Markus D Knudsen; Kana Wu; Amit D Joshi; Shuji Ogino; Edward L Giovannucci; Andrew T Chan; Mingyang Song Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-10-07 Impact factor: 4.090
Authors: Yuanjie Pang; Jun Lv; Christiana Kartsonaki; Yu Guo; Canqing Yu; Yiping Chen; Ling Yang; Zheng Bian; Iona Y Millwood; Robin G Walters; Xiaojun Li; Ju Zou; Michael V Holmes; Junshi Chen; Zhengming Chen; Liming Li Journal: Br J Cancer Date: 2021-03-26 Impact factor: 7.640
Authors: José de Jesús Rodríguez-Romero; Alba Cecilia Durán-Castañeda; Alicia Paulina Cárdenas-Castro; Jorge Alberto Sánchez-Burgos; Victor Manuel Zamora-Gasga; Sonia Guadalupe Sáyago-Ayerdi Journal: Food Chem X Date: 2021-12-22
Authors: Ming-Ming He; Zhe Fang; Dong Hang; Feng Wang; Georgios Polychronidis; Liang Wang; Chun-Han Lo; Kai Wang; Rong Zhong; Markus D Knudsen; Scott G Smith; Rui-Hua Xu; Mingyang Song Journal: Int J Cancer Date: 2020-11-02 Impact factor: 7.316